Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
-
* Corresponding author: Issaka Sagara isagara@mrtcbko.org
Malaria Journal 2009, 8:63 doi:10.1186/1475-2875-8-63
Accesses
- Last 30 days: 173 accesses
- Last 365 days: 1958 accesses
- All time: 5742 accesses
Cited by
BioMed Central: 1 citation
|
Research
Jimee Hwang, Bereket H Alemayehu, David Hoos, Zenebe Melaku, Samuel G Tekleyohannes, Takele Teshi, Sintayehu G Birhanu, Leykun Demeke, Kedir Gobena, Moges Kassa, Daddi Jima, Richard Reithinger, Henry Nettey, Michael Green, Joseph L Malone, S Patrick Kachur, Scott Filler Malaria Journal 2011, 10:209 (28 July 2011) In Ethiopia, artemether-lumefantrine has been the first-line treatment for uncomplicated P. falciparum malaria since 2004. AL remains a highly effective and well-tolerated treatment in this study setting after several years of universal access to AL.
|
